European Journal of Nuclear Medicine and Molecular Imaging
Journal Abbreviation: EUR J NUCL MED MOL I
ISSN: 1619-7070
Publisher: Springer Verlag (Germany)
Publications (49)
Potential Limitations of Established Blood-Dosimetry Models for Lu-177 Therapy (2021)
Ritt P, Jobic C, Grings A, Beck M, Schmidkonz C, Kuwert T, Uder M, Brand M
Conference contribution
Determination of Partial-Volume Effect in Patient-Individual Kidney Phantoms for Tc-99m SPECT/CT (2021)
Grings A, Kuwert T, Ritt P
Conference contribution
Normal Values of Skeletal Tc-99m-labelled Bisphosphonate Uptake in SPECT/CT (2021)
Ritt P, Heim P, Grings A, Beck M, Kuwert T
Conference contribution
Ga-68-FAPI-04 PET/CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-related interstitial lung disease (2021)
Schmidkonz C, Distler J, Treutlein C, Atzinger A, Prante O, Ritt P, Goetz T, et al.
Journal article
Imaging coronary plaques using 3D motion-compensated [18F]NaF PET/MR (2021)
Mayer J, Wurster TH, Schaeffter T, Landmesser U, Morguet A, Bigalke B, Hamm B, et al.
Journal article
Multiparametric PET and MRI of myocardial damage after myocardial infarction: correlation of integrin αvβ3 expression and myocardial blood flow (2021)
Makowski MR, Rischpler C, Ebersberger U, Keithahn A, Kasel M, Hoffmann E, Rassaf T, et al.
Journal article
The EANM guideline for radiosynoviorthesis (2021)
Kampen WU, Boddenberg-Paetzold B, Fischer M, Gabriel M, Klett R, Konijnenberg M, Kresnik E, et al.
Journal article
Hybrid PET/MR imaging for the prediction of left ventricular recovery after percutaneous revascularisation of coronary chronic total occlusions (2020)
Vitadello T, Kunze KP, Nekolla SG, Langwieser N, Bradaric C, Weis F, Cassese S, et al.
Journal article
A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients (2020)
Peeken JC, Shouman MA, Kroenke M, Rauscher I, Maurer T, Gschwend JE, Eiber M, Combs SE
Journal article
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy (2020)
Vogel MME, Kroeze SGC, Henkenberens C, Schmidt-Hegemann NS, Kirste S, Becker J, Burger IA, et al.
Journal article